Aethlon Medical, Inc. (AEMD)

NASDAQ: AEMD · USD

$5.68

+0.61 (+12.0%)· Recorded snapshot

Market cap	4M
Net income (ttm)	-6.9M
EPS (ttm)	-$31.5
Shares out	711.1K
Volume	71,210
Beta	1.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -6.9M
EPS (ttm): -$31.5
Market cap: 4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-160.9

P25 -113.8P50 -46.5P75 -0.9

ROIC-91.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All AEMD indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000882291
Company name	Aethlon Medical, Inc.
Country	United States
Country code	US
CUSIP number	00808Y703
Earnings date	2026-11-11
Earnings time	amc
Employees	9
Employees change	-5
Employees growth	-35.71%
Enterprise value	$-526,719
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	1984
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US00808Y7031
Last 10-K release date	2026-06-10
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-08-04
Last stock split type	Reverse
Market cap	$4M
Market cap category	Nano-Cap
Next earnings date	2026-11-11
Options	No
Price	$5.68
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	AEMD
U.S. state	California
Website	https://www.aethlonmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-553.71%
FCF / EV yield	1,247.68%
FCF yield	-180.3%
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	0.47x
Price / tangible book value	0.77x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-770,836
ROA	-76.69%
ROA (5Y)	-57.26%
ROCE	-136.18%
ROE	-160.91%
ROE (5Y)	-132.07%
ROIC	-91.46%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	10
EPS growth years	4
Net income growth quarters	2
Net income growth years	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12,854
Depreciation and amortization	$313,876
EBIT	$-7.1M
EBITDA	$-6.8M
EPS	$-31.45
FCF per share	$-10.11
Financing cash flow	$8.3M
Free cash flow	$-7.2M
Free cash flow minus SBC	$-7.4M
Investing cash flow	$-12,854
Net cash flow	$1.2M
Net income	$-6.9M
Operating cash flow minus SBC	$-7.4M
Operating income	$-7.1M
Stock-based compensation	$256,105

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$10.89
Debt / equity	0.07
Interest coverage	-492.66
Long-term assets	$624,457
Long-term liabilities	$-0
Net cash (debt)	$4.6M
Net cash / market cap	114.45%
Net cash growth	48.31%
Net debt / equity	-0.88
Piotroski F-Score	1
Property, plant and equipment	$525,307
Shareholders' equity	$5.2M
Tangible book value	$5.2M
Tangible book value per share	$10.89
Total assets	$6.2M
Total cash	$4.9M
Total debt	$367,608
Total liabilities	$1M
WACC	10.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$5.6M
Current liabilities	$1M
Current ratio	5.42
Net working capital	$8,901
Quick ratio	4.76
Working capital	$4.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-497.17%
Dividend yield	0%
Shareholder yield	-497.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-100%
10Y return CAGR	-66.09%
10Y total return	-100%
150-day SMA	$6.75
15Y price change	-100%
15Y return CAGR	-50.15%
15Y total return	-100%
1D price change	12.03%
1M price change	-9.55%
1M total return	-9.55%
1W price change	12.03%
1W total return	12.03%
1Y price change	-78.15%
1Y return CAGR	-78.18%
1Y total return	-78.15%
20-day SMA	$5.62
200-day SMA	$7.85
20Y price change	-100%
20Y return CAGR	-44.65%
20Y total return	-100%
3M price change	101.78%
3M total return	101.78%
3Y price change	-99.03%
3Y return CAGR	-78.7%
3Y total return	-99.03%
50-day SMA	$4.37
50-day SMA vs 200-day SMA	50under200
52-week high	$29.45
52-week high date	2025-10-29
52-week low	$1.41
52-week low date	2026-09-16
5Y price change	-99.96%
5Y return CAGR	-78.87%
5Y total return	-99.96%
6M price change	-47.65%
6M total return	-47.65%
All-time high	$30,003,000.30
All-time high date	1999-03-17
All-time low	$1.41
All-time low date	2026-09-16
Average true range (ATR)	$0.42
Average volume	61.7K
Beta (1Y)	1.8
Beta (2Y)	0.81
Beta (5Y)	1.21
Change from 52-week high	-80.71%
Change from 52-week low	302.84%
Change from all-time high	-100%
Change from all-time low	302.84%
Change from open	5.38%
Day's gap	6.31%
Dollar volume	$404,473
High price	$5.68
Low price	$5.39
Monthly RSI	33.41
Open price	$5.39
Position in 52-week range	100%
Premarket change	3.55%
Premarket close	$5.07
Premarket price	$5.25
Previous close	$5.07
Price vs 150-day SMA	-15.88%
Price vs 20-day SMA	1.05%
Price vs 200-day SMA	-27.67%
Price vs 50-day SMA	30.13%
Relative volume	1.17
RSI	57.5
Sharpe ratio	0.3
Sharpe ratio (3Y)	0.02
Sharpe ratio (5Y)	-0.21
Sortino ratio	1.5
Sortino ratio (3Y)	0.1
Sortino ratio (5Y)	-0.5
Volume	71.2K
Weekly RSI	41.9
YTD price change	-58.99%
YTD total return	-58.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	703K
Float percentage	98.86%
Shares change (QoQ)	52.56%
Shares change (YoY)	497.17%
Shares held by insiders	1.14%
Shares held by institutions	15.76%
Shares outstanding	711.1K
Short % of float	4.68%
Short % of shares	4.63%
Short ratio	0 days

Deeper analysis on AEMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AEMD report

Is a complete AEMD research report available?

No complete published report is available for Aethlon Medical, Inc. (AEMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aethlon Medical, Inc. (AEMD)

Price

Financial snapshot

Fair-value bridge

Latest news · AEMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AEMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AEMD

Frequently asked questions